July 15, 2025 10:21 AM EDT
News Briefing

Ot­su­ka buys im­munol­o­gy drugs; JCR, Acu­men team up on Alzheimer’s pro­gram

ENDPOINTS

Plus, news about UTEC, Sel­l­as and On­co­ma­tryx Bio­phar­ma:

Ot­su­ka ac­quires im­munol­o­gy drugs from Can­tar­gia: The agree­ment will send ear­ly-stage CAN10 and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Prasad again over­rode FDA vac­cine re­view­ers, this time on Mod­er­na’s Covid shot for young kids

Mer­ck­'s PD-1xVEGF part­ner LaNo­va gets snapped up for $951M

FDA ques­tions safe­ty, ef­fi­ca­cy of GSK's Blenrep in mul­ti­ple myelo­ma ahead of ad­comm

The Trump ad­min­is­tra­tion dis­band­ed a new­born screen­ing pan­el. Ad­vo­cates now face a hard­er path

BMS warns against ‘in­dis­crim­i­nate use’ of rene­go­ti­a­tions as CMS plans next drug price talks

Up­dat­ed: Af­ter Phase 3 obe­si­ty suc­cess, Hen­grui plans Chi­na ap­proval fil­ing for Kail­era-part­nered drug

A service from the Financial Times